Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06338241
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2024-03-20
Brief Title:
Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model
Sponsor:
Mario Pérez Sayáns
Organization:
University of Santiago de Compostela
Study Overview
Official Title:
Clinical Study to Analyze the Osteogenic Action of a Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model Galibone in Bone Regeneration Following the Extraction of Impacted Mandibular Third Molars
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Galibone
Brief Summary:
The clinical study aims to assess the osteogenic effects of Galibone in bone regeneration post-extraction of impacted mandibular third molars
Detailed Description:
With a focus on both clinical and radiological outcomes the study seeks to compare the efficacy of Galibone against a standard material Bio-Oss through a double-blind randomized split-mouth trial involving 30 patients Variables including pain inflammation and post-surgical complications will be monitored during the initial seven-day follow-up while bone volume reduction and mineral density will be evaluated radiographically over a six-month period The studys findings promise to shed light on the potential of Galibone as a promising adjunct in enhancing bone regeneration following dental extractions thereby advancing oral surgical practices and patient outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None